MRS-based Metabolomics in Cancer Research

Area of Science:

• Biochemistry
• Medical Diagnostics
• Analytical Chemistry

Background:

• Metabolomics, particularly Magnetic Resonance Spectroscopy (MRS)-based metabolomics, is rapidly emerging as a significant technique.
• Advances in analytical and data analysis methods enhance its diagnostic potential for various diseases.

Purpose of the Study:

• To review the applications of MRS-based metabolomics in diagnosing various cancers.
• To discuss the challenges and requirements for its clinical implementation.

Main Methods:

• A 5-stage Statistical Classification Strategy is detailed, incorporating advanced feature selection methods like genetic algorithms and novel projection techniques.
• Review of existing literature on MRS-based metabolomics applications in oncology.

Main Results:

• MRS-based metabolomics has been applied to study body fluids, tissue biopsies, and in vivo samples for diagnosing breast, prostate, colorectal, pancreatic, hepatobiliary, gastric, and brain cancers.
• Robust diagnostic classification requires studies with a sufficiently large number of subjects.

Conclusions:

• MRS-based metabolomics holds significant potential for disease diagnosis, especially in oncology.
• Overcoming challenges such as developing user-friendly instruments and educating medical professionals is crucial for its widespread clinical use.